These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses. McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. Issel CJ; Horohov DW; Lea DF; Adams WV; Hagius SD; McManus JM; Allison AC; Montelaro RC J Virol; 1992 Jun; 66(6):3398-408. PubMed ID: 1316455 [TBL] [Abstract][Full Text] [Related]
13. Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy. Mealey RH; Littke MH; Leib SR; Davis WC; McGuire TC Vet Immunol Immunopathol; 2008 Jan; 121(1-2):8-22. PubMed ID: 17727961 [TBL] [Abstract][Full Text] [Related]
14. Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition. Tagmyer TL; Craigo JK; Cook SJ; Even DL; Issel CJ; Montelaro RC J Virol; 2008 Apr; 82(8):4052-63. PubMed ID: 18234792 [TBL] [Abstract][Full Text] [Related]
15. Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses. Ridgely SL; McGuire TC Vaccine; 2002 Mar; 20(13-14):1809-19. PubMed ID: 11906769 [TBL] [Abstract][Full Text] [Related]
16. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses. Li F; Craigo JK; Howe L; Steckbeck JD; Cook S; Issel C; Montelaro RC J Virol; 2003 Jul; 77(13):7244-53. PubMed ID: 12805423 [TBL] [Abstract][Full Text] [Related]
17. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus. Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572 [TBL] [Abstract][Full Text] [Related]
18. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern. Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100 [TBL] [Abstract][Full Text] [Related]
19. Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus. Fraser DG; Oaks JL; Brown WC; McGuire TC Immunology; 2002 Mar; 105(3):295-305. PubMed ID: 11918691 [TBL] [Abstract][Full Text] [Related]
20. Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses. McGuire TC; Leib SR; Lonning SM; Zhang W; Byrne KM; Mealey RH J Gen Virol; 2000 Nov; 81(Pt 11):2735-2739. PubMed ID: 11038386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]